Skip to main content
SpringerLink
Log in
Book cover

Mechanisms of Lymphocyte Activation and Immune Regulation IV pp 57–66Cite as

The Interleukin-2 Receptor: A Target for Immunotherapy

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 323))

Abstract

Immune intervention began almost two centuries ago when Jenner introduced vaccination with cowpox as a means of protecting against smallpox. This form of immune intervention plays a dominant role in the prevention of human disease. Furthermore, immunological approaches including radioimmunoassays, enzyme-linked immunoassays, microfluorometry, and modern molecular immunogenetics are critical in clinical diagnosis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. G. Köhler and C. Milstein, Continuous cultures of fused cells secreting antibody of pre-defined specificity, Nature 256:495 (1975).

    Google Scholar 

  2. R. Catane and D.L. Longo, Monoclonal antibodies for cancer therapy, Isr. J. Med. Sci. 24:471 (1989).

    Google Scholar 

  3. T.A. Waldmann, Multichain interleukin-2 receptor: a target for immunotherapy in lymphoma, J. Natl. Cancer Inst. 81:914 (1989).

    Google Scholar 

  4. T.A. Waldmann, The interleukin-2 receptor, J. Biol. Chem. 266:2681 (1991).

    Google Scholar 

  5. P.T. Jones, P.H. Dear, J. Foote, M.S. Neuberger, and G. Winter, Replacing the complementarity-determining regions in a human antibody with those from a mouse, Nature 321:522 (1986).

    Google Scholar 

  6. C. Queen, W.P. Schneider, H.E. Selick, P.W. Payne, N.F. Landolfi, J.F. Duncan, N.M. Avdalovic, M. Levitt, R.P. Junghans, and T.A. Waldmann, A humanized antibody that binds to the IL-2 receptor, Proc. Natl. Acad. Sci. USA 86:10029 (1989).

    Google Scholar 

  7. R.P. Junghans, T.A. Waldmann, N.D. Landolfi, N.M. Avdalovic, W.P. Schneider, and C. Queen, Anti-Tac-H, a humanized antibody that binds the interleukin-2 receptor: a novel agent for immunotherapy in malignant and immune disorders, Cancer Res. 50:1495 (1990).

    Google Scholar 

  8. H. Lorberboum-Galski, R. Kozak, T. Waldmann, P. Bailon, D. FitzGerald, and I. Pastan, IL2-PE40 is cytotoxic to cells displaying either the p55 or p75 subunit of the IL-2 receptor, J. Biol. Chem. 263:18650 (1988).

    Google Scholar 

  9. V.K. Chaudhary, C. Queen, R.P. Junghans, T.A. Waldmann, D.J. FitzGerald, and I. Pastan, A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin, Nature 339:394 (1989).

    Google Scholar 

  10. R.W. Kozak, R.W. Atcher, O.A. Gansow, A.M. Friedman, J.J. Hines, and T.A. Waldmann, Bismuth-212 labeled anti-Tac monoclonal antibody: alpha-particle emitting radionuclides as modalities for radioimmunotherapy, Proc. Natl. Acad. Sci. USA 83:474 (1986).

    Google Scholar 

  11. R.W. Kozak, A. Raubitschek, S. Mirzadeh, M.W. Brechbiel, R. Junghans, O.A. Gansow, and T.A. Waldmann, Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: a critical factor in determining in vivo survival and organ toxicity, Cancer Res. 49:2639 (1989).

    Google Scholar 

  12. K.A. Smith, T-cell growth factor, Immunol. Rev. 51:337 (1980).

    Google Scholar 

  13. T.A. Waldmann, The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes, Science 232:727 (1986).

    Google Scholar 

  14. W.A. Kuziel and W.C. Greene, Interleukin-2 and the IL-2 receptor: new insights into structure and function, J. Invest. Dermatol. 94:27S (1990).

    Google Scholar 

  15. R.J. Robb, A. Munck, and K.A. Smith, T cell growth factor receptors. Quantification, specificity, and biological relevance, J. Exp. Med. 154:1455 (1981).

    Google Scholar 

  16. T. Uchiyama, S. Broder, and T.A. Waldmann, A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells, J. Immunol. 126:1393 (1981).

    Google Scholar 

  17. T. Uchiyama, D.L. Nelson, T.A. Fleischer, and T.A. Waldmann, A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells, Expression of Tac antigen on activated cytotoxic killer T-cells, suppressor cells, and one of two types of helper T cells, J. Immunol. 126:1398 (1981).

    Google Scholar 

  18. M. Tsudo, R.W. Kozak, C.K. Goldman, and T.A. Waldmann, Demonstration of a non-Tac peptide that binds interleukin-2: a potential participant in a multichain interleukin 2 receptor complex, Proc. Natl. Acad. Sci. USA 83:9694 (1986).

    Google Scholar 

  19. M. Tsudo, R.W. Kozak, C.K. Goldman, and T.A. Waldmann, Contribution of a p75 interleukin-2 binding peptide to a high-affinity interleukin-2 receptor complex, Proc. Natl. Acad. Sci. USA 84:4215 (1987).

    Google Scholar 

  20. M. Sharon, R.D. Klausner, B.R. Cullen, R. Chizzonite, and W.J. Leonard, Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions, Science 234:859 (1986).

    Google Scholar 

  21. M. Hatakeyama, M. Tsudo, S. Minamoto, T. Kono, T. Doi, T. Miyata, and T. Tomiguchi, Interleukin-2 receptor β chain gene: generation of three receptor fonns by cloned human ∝ and β chain cDNA’s, Science 244:551 (1989).

    Google Scholar 

  22. J.F. Bazan, Structural design and molecular evolution of a cytokine receptor superfamily, Proc. Natl. Acad. Sci. USA 87:6934 (1990).

    Google Scholar 

  23. J. Szöllösi, S. Damjanovich, C.K. Goldman, M.J. Fulwyler, A.A. Aszalos, G. Goldstein, P. Rao, M.A. Talle, and T.A. Waldmann, Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide tenned T27 with the 55-kDa Tac peptide, Proc. Natl. Acad. Sci. USA 84:7246 (1987).

    Google Scholar 

  24. M. Sharon, J.R. Gnarra, M. Bamiyash, and W.J. Leonard, Possible association between IL-2 receptors and class I HLA molecules on T cells, J. Immunol. 141:3512 (1988).

    Google Scholar 

  25. J. Burton, C.K. Goldmann, P. Rao, M. Moos, and T.A. Waldmann, The association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin-2 receptor, Proc. Natl. Acad. Sci. USA 87:7329 (1990).

    Google Scholar 

  26. M. Edidin, A. Aszalos, S. Damjanovich, and T.A. Waldmann, Lateral diffusion measurements give evidence for association of the Tac peptide of the IL-2 receptor with the T27 peptide in the plasma membrane of HUT-102-B2 T cells, J. Immunol. 141:1206 (1988).

    Google Scholar 

  27. L.A. Rubin, C.C. Kurman, W.E. Biddison, N.D. Goldman, and D.L. Nelson, A monoclonal antibody 7G7/B6 binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac, Hybridoma 4:91 (1985).

    Google Scholar 

  28. T.A. Waldmann, W.C. Greene, P.S. Sarin, C. Saxinger, D.W. Blayney, W.A. Blattner, C.K. Goldman, K. Bongiovanni, S. Sharrow, J.M. Depper, W. Leonard, T. Uchiyama, and R.C. Gallo, Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T-cell leukemia with human T-cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac: monoclonal antibody identifying the human receptor for T cell growth factor, J. Clin. Invest. 73:1711 (1984).

    Google Scholar 

  29. T. Uchiyama, T. Hori, M. Tsudo, Y. Wano, H. Umadome, S. Tamori, J. Yodoi, M. Maeda, H. Sawami, and H. Uchino, Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells, J. Clin. Invest. 76:446 (1985).

    Google Scholar 

  30. R. Schwarting, J. Gerdes, and H. Stein, Expression of interleukin-2 receptor on Hodgkin’s and non-Hodgkin’s lymphoma and macrophages, J. Clin. Pathol. 38:1196 (1985).

    Google Scholar 

  31. S.J. Korsmeyer, W.C. Greene, J. Cossman, S.M. Hsu, J.P. Jensen, L.M. Neckers, S.L. Marshall, A. Bakhshi, J.M. Depper, W.J. Leonard, E.S. Jaffe, and T.A. Waldmann, Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia, Proc. Natl. Acad. Sci. USA 80:4522 (1983).

    Google Scholar 

  32. T. Diamantstein and H. Osawa, The interleukin-2 receptor, its physiology and a new approach to a selective immunosuppressive therapy by anti-interleukin-2 receptor monoclonal antibodies, Immunol. Rev. 92:5 (1986).

    Google Scholar 

  33. T. Uchiyama, J. Yodoi, K. Sagawa, K. Takatsuki, and H. Uchino, Adult T-cell leukemia: clinical and hematologic features of 16 cases, Blood 50:481 (1977)

    Google Scholar 

  34. B.J. Poiesz, F.W. Ruscetti, A.F. Gazdar, P.A. Bunn, J.D. Minna, and R.C. Gallo, Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, Proc. Natl. Acad. Sci. USA 77:7415 (1980).

    Google Scholar 

  35. M. Seiki, S. Hattori, Y. Hirayama, and M. Yoshida, Human adult T-ce1lleukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA, Proc. Natl. Acad. Sci. USA 80:3618 (1983).

    Google Scholar 

  36. J.G. Sodroski, C.A. Rosen, and W.A. Haseltine, Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells, Science 225:381 (1984).

    Google Scholar 

  37. T.A. Waldmann, C.K. Goldman, K.F. Bongiovanni, S.O. Sharrow, M.P. Davey, K.B. Cease, S.J. Greenberg, and D. Longo, Therapy of patients with human T cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2, Blood 72:1805 (1988).

    Google Scholar 

  38. T.A. Waldmann, Monoclonal antibodies in diagnosis and therapy, Science 252:1659 (1991).

    Google Scholar 

  39. M. Maeda, N. Arima, Y. Daitoku, M. Kashihara, H. Okamoto, T. Uchiyama, K. Shirono, M. Matsuka, T. Hattori, K. Takatsuki, K. Ikuta, A. Shimuzu, T. Honjo, and J. Yodoi, Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T-cell leukemia, Blood 70:1407 (1987).

    Google Scholar 

  40. J.M. Depper, W.J. Leonard, T.A. Waldmann, and W.C. Greene, Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation, J. Immunol. 131:690 (1983).

    Google Scholar 

  41. R.L. Kirkman, L.V. Barrett, and G.N. Gaulton, Administration of an anti interleukin-2 receptor monoclonal antibody prolongs cardiac allograft survival in mice, J. Exp. Med. 162:358 (1985).

    Google Scholar 

  42. M.H. Reed, M.E. Shapiro, T.B. Strom, E.L. Milford, C.B. Carpenter, D.S. Weinberg, K.A. Reimann, N.L. Letvin, T.A. Waldmann, and R.L. Kirkman, Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody, Transplantation 47:55 (1989).

    Google Scholar 

  43. P.S. Brown, Jr., G.L. Parenteau, F.M. Dirbas, R.J. Garsia, C.K. Goldman, M.A. Bukowski, R.P. Junghans, C. Queen, J. Hakimi, W. Benjamin, R.E. Clark, and T.A. Waldmann, Anti-Tac-H, a humanized antibody to the interleukin-2 receptor prolongs primate cardiac allograft survival, Proc. Natl. Acad. Sci. USA 88:2663 (1991).

    Google Scholar 

  44. R.L. Kirkman, M.E. Shapiro, C.B. Carpenter, D.B. McKay, D.L. Milford, E.L. Ramos, N.L. Tilney, T.A. Waldmann, C.E. Zimmerman, and T.B. Strom, A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation, Transplantation 51:107 (1991).

    Google Scholar 

  45. J. Hwang, D.J. FitzGerald, P. Adhya, and I. Pastan, Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli, Cell 48:129 (1987).

    Google Scholar 

  46. R.I. Kreitman, V.K. Chaudhary, T.A. Waldmann, M.C. Willingham, D.I. FitzGerald, and I. Pastan, The recombinant immunotoxin anti-Tac (Fv)-PE40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia, Proc. Natl. Acad. Sci. USA 87:8291 (1990).

    Google Scholar 

  47. M.M. Cooper, R.C. Robbins, C.K. Goldman, S. Mirzadeh, C. Stone, O.A. Gansow, R.E. Clark, and T.A. Waldmann, Use of yttrium-90-labeled anti-Tac antibody in primate xenograft transplantation, Transplantation 50:760 (1990).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Metabolism Branch, National Cancer Institute National Institutes of Health, Bethesda, MD, 20892, USA

    Thomas A. Waldmann, Carolyn Goldman, Lois Top, Angus Grant, Jack Burton, Richard Bamford, Erich Roessler, Ivan Horak, Sara Zaknoen, Claude Kasten-Sportes, Jeffrey White & David Nelson

Authors
  1. Thomas A. Waldmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carolyn Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lois Top
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Angus Grant
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jack Burton
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Richard Bamford
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Erich Roessler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ivan Horak
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sara Zaknoen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Claude Kasten-Sportes
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jeffrey White
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. David Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of California, Irvine, California, USA

    Sudhir Gupta

  2. National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

    Thomas A. Waldmann

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Waldmann, T.A. et al. (1992). The Interleukin-2 Receptor: A Target for Immunotherapy. In: Gupta, S., Waldmann, T.A. (eds) Mechanisms of Lymphocyte Activation and Immune Regulation IV. Advances in Experimental Medicine and Biology, vol 323. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3396-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3396-2_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6500-6

  • Online ISBN: 978-1-4615-3396-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation